QQQ   563.81   (+0.46%)
Why Meta’s AI Titan Clusters Are a Game-Changer for Broadcom
5 Stocks to Buy and Hold for the Rise of Physical AI
2 Chinese Stocks That Could Leave U.S. Tech in the Dust
4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise
The Bottom Is in for Kohl’s, But Let the Share Price Come to You
What's Behind Opendoor Technologies' Rally? Is Meme Mania Back?
Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound
QQQ   563.81   (+0.46%)
Why Meta’s AI Titan Clusters Are a Game-Changer for Broadcom
5 Stocks to Buy and Hold for the Rise of Physical AI
2 Chinese Stocks That Could Leave U.S. Tech in the Dust
4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise
The Bottom Is in for Kohl’s, But Let the Share Price Come to You
What's Behind Opendoor Technologies' Rally? Is Meme Mania Back?
Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound
Free Trial

Nihon Kohden (OTCMKTS:NHNKY) Shares Down 5.5% - Here's What Happened

Nihon Kohden logo with Medical background

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) dropped 5.5% on Tuesday . The stock traded as low as $11.07 and last traded at $12.52. Approximately 870 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 5,613 shares. The stock had previously closed at $13.25.

Nihon Kohden Stock Performance

The stock has a market capitalization of $2.04 billion, a P/E ratio of 21.32 and a beta of 0.37. The stock has a 50-day moving average price of $12.17 and a two-hundred day moving average price of $13.48.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported $0.18 earnings per share for the quarter. Nihon Kohden had a net margin of 6.23% and a return on equity of 7.20%. The business had revenue of $439.11 million for the quarter.

About Nihon Kohden

(Get Free Report)

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

Featured Articles

Should You Invest $1,000 in Nihon Kohden Right Now?

Before you consider Nihon Kohden, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.

While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines